| Ms Jackie Lynn Rehnstrom, LPN | |
|
500 W Fort St, Boise, ID 83702-4501 | |
| (208) 422-1000 | |
| Not Available |
| Full Name | Ms Jackie Lynn Rehnstrom |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 500 W Fort St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144956640 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 15700 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jackie Lynn Rehnstrom, LPN 500 W Fort St, Boise, ID 83702-4501 Ph: (208) 422-1000 | Ms Jackie Lynn Rehnstrom, LPN 500 W Fort St, Boise, ID 83702-4501 Ph: (208) 422-1000 |
News Archive
"In 1993 the United Nations General Assembly declared 22 March as World Day for Water, and people have embraced the entire week in an attempt to shine the spotlight on the global water issues," Carl Hensman, a program officer in the water, sanitation, and hygiene program at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog.
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Millennium Research Group (MRG) has conducted a detailed and thorough analysis of the acute care clinical information systems (CIS) market and finds that a major driver in the US is the demand for improvement in patient safety.
How do immune cells manage to sort through vast numbers of similar-looking proteins within the body to detect foreign invaders and fight infections?
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publication of a scientific article in the renowned Journal of Urology, supporting the development of the Company's PI3K/Akt pathway inhibitor oral compound, perifosine, for the treatment of cancer.
› Verified 7 days ago
James Hd Hecht, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1536 | |
Mr. Brian Lynn Lambrecht, NURSE Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Mandie Marie Phillips, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 Fax: 208-422-1051 | |
Harjit Kaur Gala, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Rodney D Mcalpin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 | |
Briana Rae Budell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort Steet, Building 28 Room G05, Boise, ID 83702 Phone: 208-422-1000 |